Bumetanide
NDC 67184-0593, Bumetanide, injection, from Qilu Pharmaceutical Co., Ltd..
- Product NDC
- 67184-0593
- Status
- Listed
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219116
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0593 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUMETANIDE.25 mg/mL
Pharmacologic classes
Increased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67184-0593-2 | 67184059302 | 10 VIAL in 1 CARTON (67184-0593-2) / 4 mL in 1 VIAL (67184-0593-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ef5fe12a-f8ee-4ba7-932b-51bbaccf6575
Use it
Look up 67184-0593 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0593 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67184-0593. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.